Home Tags Asthma

Asthma Related Content

asthma medications

Supporting the addition of asthma medications to the exemption list in the UK

Dr Fred A. Wagshul, Pulmonologist and Medical Director at the Lung Center of America explains why he supports the addition of asthma medications to the exemption list in the UK.
respiratory protection

Why is respiratory protection so important?

Paul Riddick, Co-Founder and Technical Director at Vodex explores how contaminates being produced on a daily basis in the workplace can damage your health and could even prove fatal.
Chronic conditions, Type 2 Diabetes, Asthma, healthcare professionals, Napp, Health service

Napp: Reducing the burden of chronic conditions through partnership

Chronic conditions, such as asthma and diabetes, are creating an increasing burden on the health service.
cell-cell interaction, astma

Does disturbed cell-cell interaction cause asthma?

Michael Roth, Research Group Leader at University Hospital Basel asks if disturbed cell-cell interaction causes asthma and provides a fascinating response.
prescription charges, asthma

How unfair prescription charges are putting people with asthma at risk

Asthma UK’s recent report reveals the debilitating impact asthma prescription charges are having on people’s health and wellbeing. Dr Samantha Walker, Director of Policy and Research at Asthma UK explains more.
Pneumology & Pulmonary Cell Research university hospital basel

Health research: Why can asthma still not be cured?

Prof Dr Michael Roth poses the big question about asthma and the lack of a cure, discussing the causes and medications used to help control it.
inequality

How inequality leads to poor asthma outcomes

Dr Samantha Walker, Director of Research and Policy details how inequality in the UK leads to poor asthma outcomes
Why can asthma still not be cured

Health research: Why can asthma still not be cured?

Michael Roth, Research Group Leader at the University Hospital Basel explains what asthma is, its health impact and charts research landscape in the field.
Asthma and COPD

Do we know the cause of asthma and COPD?

Michael Roth, Research Group Leader at the University Hospital Basel & University Basel share his expertise on asthma and COPD, the most prevalent chronic inflammatory diseases of the lung globally
people with asthma

Why thousands of people with asthma could be missing out on life-changing treatment

Asthma UK’s recent report explores the barriers to life-changing treatment for people with uncontrolled asthma, as Joe Farrington-Douglas, Head of Policy and External Affairs at Asthma UK explains.
dyspnoea

Dyspnoea (breathlessness): Still an ongoing battle

Katy Beckford and Alex Christie from the Association of Respiratory Nurse Specialists detail precisely why dyspnoea (breathlessness) remains an ongoing battle today
asthma in Ireland

The key challenges around asthma in Ireland

In this interview, Sarah O’Connor, CEO of the Asthma Society of Ireland charts today’s key challenges around asthma in Ireland and beyond
chronic inflammatory lung diseases

The need to improve the diagnosis of chronic inflammatory lung diseases

Michael Roth, Research Group Leader at University Hospital Basel argues for the clear need to improve the diagnosis of chronic inflammatory lung diseases
dyspnoea

An introduction to shortness of breath (dyspnoea)

NHS 24 provides an introduction to sudden shortness of breath, which is also known as breathing difficulty (dyspnoea)
pesticides

Pesticides: A contributing factor to the increase in asthma?

Pamela J. Lein at the University of California, Davis discusses the evidence suggesting that pesticides are risk factors for asthma
asthma care in the UK

How using data can transform asthma care in the UK

Kay Boycott, Chief Executive of Asthma UK tells us how using data can transform asthma care today
chronic inflammatory lung diseases

Asthma: Understanding chronic inflammatory lung diseases

Michael Roth, Research group leader at the University & University Hospital Basel explores the current state of chronic inflammatory lung diseases, from the molecular biology perspective
health data

Asthma sufferers willing to share data to improve care and research

A recent report from Asthma UK has shown that nine in ten people (88%), living with asthma in England are in favour of sharing their data to improve NHS services

Do we know the cause of asthma and COPD

Prof Dr Michael Roth (PhD), Research Group Leader Pulmonary Cell Research at the University Hospital Basel in Switzerland explains the extent to which asthma and COPD (smoker’s lung) are the most prevalent chronic inflammatory diseases of the lung, globally
Severe asthma

Severe asthma shows the tip of the iceberg of personalised medicine

Isabel Proaño Gómez, Communications Manager at European Federation of Allergies and Airways Diseases Patients’ Associations (EFA) explores the issue of severe asthma and how our understanding of it is evolving

Follow Open Access Government